Peizhang Li

机构：Beijing Institute of Technology · ORCID：0009-0007-8783-8613

发表论文 51 篇 · 总被引 332 次 · h-index 10

代表论文

• ELK1-mediated YTHDF1 drives prostate cancer progression by facilitating the translation of Polo-like kinase 1 in an m6A dependent manner (2022 · International Journal of Biological Sciences · 被引 47)
• E2F transcription factor 2-activated DLEU2 contributes to prostate tumorigenesis by upregulating serum and glucocorticoid-induced protein kinase 1 (2022 · Cell Death and Disease · 被引 21)
• Reprogramming hormone-sensitive prostate cancer to a lethal neuroendocrine cancer lineage by mitochondrial pyruvate carrier (MPC) (2022 · Molecular Metabolism · 被引 18)
• MAFG-AS1 is a prognostic biomarker and facilitates prostate cancer progression (2022 · Frontiers in Oncology · 被引 9)
• Novel Compound Heterozygous Pathogenic Mutations of SLC5A5 in a Chinese Patient With Congenital Hypothyroidism (2021 · Frontiers in Endocrinology · 被引 9)
• A nomogram based on inflammation and nutritional biomarkers for predicting the survival of breast cancer patients (2024 · Frontiers in Endocrinology · 被引 8)